Renalytix plc

About Renalytix plc

Renalytix is a company focused on transforming kidney disease care through innovative technology. Their mission is to shift the focus from kidney disease to kidney health, providing early-stage risk assessment for diabetic kidney disease using their KidneyIntelX™ technology. This helps clinicians improve kidney and renal-cardio-metabolic outcomes by targeting resources and treatments effectively.

Products & Services

KidneyIntelX™:A technology that uses a simple blood test to assess the risk of progressive decline in kidney function in early stages of diabetic kidney disease, enabling better resource allocation and treatment.

kidneyintelX.dkd™:A prognostic blood test with FDA marketing authorization (Q2 2023) and Medicare coverage determination (June 2024). It predicts risk levels for kidney function decline over 5 years in adults with type 2 diabetes and chronic kidney disease stages 1-3b.

Specialties

Kidney Disease Care Diabetic Kidney Disease Risk Assessment Prognostic Blood Testing Renal-Cardio-Metabolic Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 4000000 MR: - FA: up to $4 million FAN: 4000000	D: 2024-04-08 FD: 2024-04-08	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 20300000 MR: - FA: c. $20.3 million FAN: 20300000	D: 2023-02-08 FD: 2023-02-08	5 investors
3	RT: Grant T: - FT: Grant	A: 10000000 MR: - FA: 10 million FAN: 10000000	D: 2023-01-26 FD: 2023-01-26	1 investors

Registered Direct Offering Latest

2024-04-08

$4.0M

1 investor (Pro only)

Private Placement 2023-02-08

$20.3M

Grant 2023-01-26

$10.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James McCullough

CEO

F

Fergus Fleming

CTO

H

Howard Doran

President

J

Joel R. Jung

Interim CFO

M

Michael J. Donovan

Chief Medical Officer

J

Julian Baines

Executive Chairman

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Renalytix plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised